|
|
Volumn 6, Issue 2, 1999, Pages 373-376
|
|
The implications of proliferation and apoptosis for lung cancer metastasis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CASP3 PROTEIN, HUMAN;
CASPASE;
CASPASE 3;
CYCLIN A;
CYCLINE;
FAS ANTIGEN;
FAS LIGAND;
FASLG PROTEIN, HUMAN;
MEMBRANE PROTEIN;
PROTEIN BCL 2;
ADENOCARCINOMA;
APOPTOSIS;
ARTICLE;
CANCER STAGING;
CELL CYCLE;
CELL DIVISION;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LARGE CELL CARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
MIDDLE AGED;
PATHOLOGY;
RISK FACTOR;
SQUAMOUS CELL CARCINOMA;
ADENOCARCINOMA;
ANTIGENS, CD95;
APOPTOSIS;
CARCINOMA, LARGE CELL;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CASPASE 3;
CASPASES;
CELL CYCLE;
CELL DIVISION;
CYCLIN A;
FAS LIGAND PROTEIN;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
NEOPLASM STAGING;
PROLIFERATING CELL NUCLEAR ANTIGEN;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 0033091920
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.6.2.373 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
